Collectively, these results show that metformin-treated bone marrow cells differentiate into spindle-shaped macrophages displaying increased phagocytic activity and glioma cell cytotoxicity together with modulated expression of MHC class I and CD80 molecules, suggesting that these cells acquire a distinct immunological phenotype when compared with corresponding untreated macrophages. This evidence concerns the gene CD80 and glioma.